About the 2016 Forum

Following the success of last year’s event, we are delighted to bring you the 4th Annual LIFE SCIENCES LAW FORUM on 23 June 2016 in London.

This year’s programme focuses on equipping you and your team with practical solutions and strategies for addressing the challenges your organisation might face throughout the product life cycle.

In-house counsel and private practitioners will cover both the technical elements of the law as well as their experience in overcoming those challenges.

Attend this Forum to hear practical solutions enabling you to:

  • GAIN an overview of legal issues on the context of commercial, reimbursement and supply chain considerations
  • INCREASE your in-depth understanding of balancing data privacy and data transparency duties within varied legal frameworks
  • UNDERSTAND where the regulators are going next and what is driving regulatory change
  • IDENTIFY new areas of legal challenges presented by innovative developments such as Digital Health
  • EFFECTIVELY manage key risk across your business
  • MEET AND ENGAGE with your industry counterparts and international experts to equip yourself with knowledge and contacts

Key themes at the forum include:

  1. European Transparency, Regulatory & Market Access
  2. Transparency of clinical trial data
  3. Pricing reimbursement update – 2016 EU commission report
  4. Biosimilars – regulatory developments
  5. Issues in collaboration agreements
  6. Product liability claims – lessons learned from recent cases
  7. Product strategies for managing risk
  8. Collaboration agreements – what are the best jurisdictions to resolve disputes? Drafting tips
  9. Privacy management in life sciences
  10. Digital Lifesciences – Legal and Regulatory Developments
  11. m-health, use of apps, security

We asked our delegates what they most enjoyed about the 2015 conference, here’s what they said:

Great caliber of speakers, diverse programme, good venue.
– Karla Burke, Thomson Reuters – IP & Science 

– Migle Dereskeviciulte, Valiunas Ellex

Catching up with relevant industry panels.
– Edward Rees, Norgine

Sharing experiences with fellow counsel.
– Naude De Iuerll, Aspen

Range of topics covered
– Soovankar Goswami, Lonza Biologics

To view the 2015 website, including the agenda, speakers, sponsors and more please click here.

2015 delegates include:

  • AbbVie
  • Actavis
  • Addleshaw Goddard
  • Arthur Cox
  • Aspen Pharma Ireland
  • Beiersdorf
  • CMS Cameron McKenna
  • DLA Piper
  • EISAI Europe
  • Eversheds
  • Fieldfisher
  • Gilead Sciences Europe
  • GSK
  • LA-SER Group
  • Lonza Biologics
  • Mathesons
  • MedImmune
  • Merck Sharp & Dohme
  • Nabarro
  • Norbrook Laboratories
  • Norgine
  • Novartis International AG
  • Omega Pharma
  • Otsuka Pharmaceuticals Europe
  • PLMJ, Sociedade de Advogados, RL
  • Ranbaxy Europe
  • Roche Diagnostics
  • Ropes & Gray
  • RPC
  • Shire
  • Sinclair Pharmaceuticals
  • SRS Advogados
  • Teva
  • Thomson Reuters
  • Transparency International
  • Valiunas Ellex
  • Walder Wyss AG
  • WIPR